Monograph
C01EB10 - Adenosine |
Not porphyrinogenic |
NP |
Rationale
Endogenous nucleoside. No relevant CYP metabolism.
Chemical description
Endogenous nucleoside.
Therapeutic characteristics
Used to stop paroxysmal supraventricular tachycardia.
Metabolism and pharmacokinetics
Adenosine is an endogenous nucleoside. Adenosine is rapidly taken up by most types of cells, including cellular elements of the blood (erythrocytes) and vascular endothelium, where it is rapidly degraded by deamination to inosine and subsequently to hypoxanthine. In addition, adenosine also undergoes phosphorylation to adenosine monophosphate (AMP) inside blood cells. Half time in blood less than 10 seconds. Non-CYP metabolism.
Published experience
Adenosine monophosphate has been proposed and used as a therapeutic agent in the acute porphyrias in the late 60s (Wiontzek, bibliographic data only + Oaks)
Similar drugs
References
# | Citation details | PMID |
---|---|---|
* | Scientific articles | |
1. | Acute intermittent porphyria. Report of a case treated with adenosine 5 phosphoric acid. Dermatologica 1969; 138(1):10-18.
Oaks WW, Schultz J, Fleischmajer R. |
5764297 |
2. | [Treatment of acute intermittent prophyria using adenosine monophosphoric acid]. Med Klin 1969; 64(27):1238-1240.
Wiontzek H. |
5799781 |
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
© NAPOS 2025